Latest News

What Happened? Shares of cloud security and performance company Cloudflare (NYSE:NET) jumped 3.4% in the afternoon session after momentum from the company's ...

Compugen (NASDAQ:CGEN) outlined the clinical rationale for its COM701 antibody in platinum-sensitive ovarian cancer and described an expansion of its AI-powered discovery platform into tumor-associated antigen, or TAA, research during a company update event. President and Chief Executive Officer Er

What Happened? Shares of online money transfer platform Remitly (NASDAQ:RELY) jumped 7.5% in the afternoon session after William Blair added the company to i...

What Happened? Shares of online grocery delivery platform Instacart (NASDAQ:CART) jumped 3.7% in the afternoon session after Wells Fargo raised its price tar...

What Happened? Shares of telecommunications and cable services provider Optimum Communications (NYSE:OPTU) jumped 6% in the afternoon session after the compa...

The healthcare stock's elevated valuation bakes in high expectations, leaving little room for error.

A maturing GIC may offer an attractive guaranteed rate, but long-term investors could sacrifice considerably more growth by renewing automatically.

AMD is posting strong AI chip growth with high-profile customer wins. Intel is recovering, with its fastest revenue growth in 15 years, but execution risk remains.

Canada’s major-project push is creating real contract opportunities for one increasingly busy TSX infrastructure builder.

XRP's future could still be bright, but it's important to keep your expectations in check.

OAS is rising with headline inflation, but individual retirement expenses can increase much faster than the national average.

As AI models become widely available, trusted professional data could become a more valuable competitive advantage.

Many dividend investors may be overlooking Pfizer's stock, and that could be a costly mistake.

Pacific Gas & Electric (NYSE:PCG) is evaluating a broad range of strategic alternatives, including potential changes to capital allocation and business structure, as it seeks to strengthen its credit profile amid continued wildfire-related financial risk in California. Speaking during an S&

Higher government-bond yields pressure utility valuations, but long-term investors can use that competition to find better entry points.

Next time the stock market is going through a big sell-off, I'll remind myself to stay humble, stay confident -- and get ready to buy more stocks.

The addition of Genmab's Epkinly to a standard cocktail of drugs helped lymphoma patients live longer before worsening.

A $500 monthly TFSA income target requires $6,000 annually, and higher yields dramatically reduce the capital required.

AbbVie and Medtronic are both stable blue chip dividend plays in this choppy market.

Air Canada's enormous share repurchase could boost future per-share results, but it doesn't remove the risks of owning an airline.

Coca-Cola is a reliable long-term investment, but it isn't a perfect one.

After dipping 2% lower last week, Nabors stock is heading in the other direction.

Investors now pay nearly three times Intuit's forward earnings multiple to own Atlassian, the faster grower with a small net loss.

The e-commerce tools provider got a strong vote of confidence from Wall Street.

IPO activity fell in the third quarter, as the stock market slumped in September and a few companies delayed listings. But Wall Street is waiting for Anthropic's IPO.